Ton Büchner, CEO of Akzo Nobel, tells CNBC that the company is selling its US operations as it lacks critical mass in North America and would require significant additional funding to be profitable.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT